ArticlePediatric blood & cancer2021

Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia.

Cristina F Contreras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.